E
Profound Medical Corp. PRN.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -48.27% -14.82% 0.84% -7.60% 3.50%
Total Depreciation and Amortization -13.36% -7.14% 5.03% 75.72% 59.74%
Total Amortization of Deferred Charges -- -- -- -92.50% --
Total Other Non-Cash Items -27.58% -51.15% -57.53% -49.15% -48.25%
Change in Net Operating Assets 361.85% 66.74% 379.69% 645.51% 129.36%
Cash from Operations -51.83% -24.36% -0.38% -11.31% 4.10%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid 8.82% -65.76% -187.84% -178.59% -153.28%
Issuance of Common Stock 70.90% 69.15% 2,228.62% 760.90% 710.49%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -63.31% -63.31% -- -1,147.65% -1,147.65%
Cash from Financing 78.26% 69.90% 2,896.78% 110.13% 108.96%
Foreign Exchange rate Adjustments 120.04% -319.21% -735.83% -412.80% -2,391.84%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 121.48% 391.19% 241.35% 48.33% 62.78%